International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 5 , Pages 1335-1342 , 1 April 2009

Sensorineural Hearing Loss After Treatment of Nasopharyngeal Carcinoma: A Longitudinal Analysis

  • S.H. Chan, F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong
    • Corresponding Author InformationReprint requests to: S. H. Chan, F.R.C.R., Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, 3 Lok Man Rd., Chai Wan, Hong Kong. Tel: (852) 2595-4180; Fax: (852) 2515-1266
  • ,
  • W.T. Ng, F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong
  • ,
  • K.L. Kam, F.R.C.S.

      Affiliations

    • Department of Otorhinolaryngology, Pamela Youde Nethersole Eastern Hospital, Hong Kong
  • ,
  • Michael C.H. Lee, Ph.D.

      Affiliations

    • Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong
  • ,
  • C.W. Choi, M.Sc.

      Affiliations

    • Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong
  • ,
  • T.K. Yau, F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong
  • ,
  • Anne W.M. Lee, F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong
  • ,
  • S.K. Chow, F.R.C.S.

      Affiliations

    • Department of Otorhinolaryngology, Pamela Youde Nethersole Eastern Hospital, Hong Kong

Received 24 May 2008 ,Revised 7 July 2008 ,Accepted 8 July 2008.

References 

  1. Leach W. Irradiation of the ear. J Laryngol Otol. 1965;79:870–880
  2. Hoistad DL, Ondrey FG, Mutlu C, et al. Histopathology of human temporal bone after cis-platinum, radiation, or both. Otolaryngol Head Neck Surg. 1998;118:825–832
  3. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol. 1998;16:1310–1317
  4. Lee AW, Lau WH, Tung SY, et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol. 2005;23:6966–6975
  5. Wee J, Tan EH, Tai BC, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol. 2005;23:6730–6738
  6. Lin JC, Jan JS, Hsu CY, et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival. J Clin Oncol. 2003;21:631–637
  7. Chan AT, Leung SF, Ngan RK, et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst. 2005;97:536–539
  8. Lee AW, Yau TK, Wong DH, et al. Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation. Int J Radiat Oncol Biol Phys. 2005;63:1331–1338
  9. Ng WT, Chan SH, Lee AW, et al. Parapharyngeal extension of nasopharyngeal carcinoma: Still a significant factor in era of modern radiotherapy?. Int J Radiat Oncol Biol Phys. 2008;72:1082–1089
  10. Lee AWM, Perez CA, Law SCK, et al. Nasopharynx. In:  Halperin EC,  Perez CA,  Brady LW editor. Principles and practice of radiation oncology. 5th ed.. Philadelphia: Lippincott Williams & Wilkins; 2008;p. 820–857
  11. Kwong DL, Wei WI, Sham JS, et al. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: A prospective study of the effect of radiation and cisplatin treatment. Int J Radiat Oncol Biol Phys. 1996;36:281–289
  12. Honore HB, Bentzen SM, Moller K, et al. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: Individualized risk estimation. Radiother Oncol. 2002;65:9–16
  13. Bentzen SM, Tucker SL. Quantifying the position and steepness of radiation dose–response curves. Int J Radiat Biol. 1997;71:531–542
  14. Oh YT, Kim CH, Choi JH, et al. Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma. Radiother Oncol. 2004;72:79–82
  15. Chen WC, Jackson A, Budnick AS, et al. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer. 2006;106:820–829
  16. Low WK, Toh ST, Wee J, et al. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: A single, blinded, randomized study. J Clin Oncol. 2006;24:1904–1909
  17. Grau C, Moller K, Overgaard M, et al. Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1991;21:723–728
  18. Pan CC, Eisbruch A, Lee JS, et al. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys. 2005;61:1393–1402
  19. Bhandare N, Antonelli PJ, Morris CG, et al. Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys. 2007;67:469–479
  20. Raaijmakers E, Engelen AM. Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature. Radiother Oncol. 2002;65:1–7
  21. Taylor I, Taylor MM. Psycholinguistics—Learning and using languages. London: Prentice Hall; 1990;
  22. Hornsby BW, Ricketts TA. The effects of hearing loss on the contribution of high- and low-frequency speech information to speech understanding. II. Sloping hearing loss. J Acoust Soc Am. 2006;119:1752–1763
  23. Hornsby BW, Ricketts TA. The effects of hearing loss on the contribution of high- and low-frequency speech information to speech understanding. J Acoust Soc Am. 2003;113:1706–1717
  24. Kam MK, Teo PM, Chau RM, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440–1450
  25. Teo PM, Leung SF, Tung SY, et al. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: A study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG). Radiother Oncol. 2006;79:27–33

 Accepted as a poster presentation at European Society for Therapeutic Radiology and Oncology Annual Congress, Goteborg, September 2008.

 Conflict of interest: none.

PII: S0360-3016(08)03174-X

doi: 10.1016/j.ijrobp.2008.07.034

International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 5 , Pages 1335-1342 , 1 April 2009